FDA Approved: LANSOPRAZOLE — Supplemental Application (Medcore LLC)

View source ↗

Summary

The FDA approved a supplemental application for lansoprazole from Medcore LLC, enabling a generic lansoprazole product to be marketed under the ANDA pathway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Helicobacter Pylori Infection
• Nsaid-induced Gastroduodenal Ulcer
• Peptic Ulcer Disease

Drugs mentioned

• Lansoprazole (Lansoprazole)

Snippet

SUPPL AP for LANSOPRAZOLE (LANSOPRAZOLE)